Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$65,215.00

Novel tool to evaluate integrative somatosensory processing in people with central neuropathic pain after spinal cord injury spinal cord injury

FY 2008-09

Summary
Central neuropathic pain (CNP) is a devastating, unrelenting pain that can occur after a disease or injury to the central nervous system such as stroke, multiple sclerosis, or spinal cord injury (SCI). CNP adversely impacts the quality of life of individuals with SCI. There are no successful treatments for CNP in part because the mechanisms underlying CNP vary between patients. Animal studies have identified a number of nervous system abnormalities that produce the symptoms similar to CNP in humans. Unfortunately, it is difficult to translate the findings from animal studies into simple tests that can be used in humans to identify the specific mechanism(s) that produce each individual's CNP. One mechanism of CNP is the release of normal inhibitory control of thermosensory pathways or "thermosensory disinhibition", that is, the loss of the normal inhibition of pain by cold following damage to the temperature pathway. We will develop a thermal grill (TG) apparatus to enable the determination of a psychophysical measure called the thermal grill illusion (TGI) in individuals with CNP. The TG produces is an illusion of pain that can be used to detect the presence or absence cold inhibition of pain within the central nervous system. Prior research has shown that the TGI could be used for this purpose, but, as yet there is no commercially available TG. Furthermore, the TGI has only been tested on the hand or forearm of able-bodied individuals, but CNP can occur in any area of the body. The new TG ("REL-TG") will enable us to evaluate the TGI in multiple body regions among individuals with SCI-related CNP. This complex process requires close collaboration of engineers, clinicians, and neuroscientists to develop a simple test that can be used both clinically (at the bedside) and experimentally (in research studies) to identify the existence of a pain producing mechanism among individuals with CNP. The final phase of this project will provide pilot data for future studies that will identify subgroups of patients with TGI and allow correlation of the findings with the underlying CNP mechanism(s). Successful REL-TG development and testing will represent a major advancement in the ability to guide mechanism-based therapeutic approaches for CNP.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
350980-2008
Name nom
Hunter, Judith
Department département
Physical Therapy
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
65215
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
3
Application title
Novel tool to evaluate integrative somatosensory processing in people with central neuropathic pain after spinal cord injury spinal cord injury
Keyword
NA
Application summary
Central neuropathic pain (CNP) is a devastating, unrelenting pain that can occur after a disease or injury to the central nervous system such as stroke, multiple sclerosis, or spinal cord injury (SCI). CNP adversely impacts the quality of life of individuals with SCI. There are no successful treatments for CNP in part because the mechanisms underlying CNP vary between patients. Animal studies have identified a number of nervous system abnormalities that produce the symptoms similar to CNP in humans. Unfortunately, it is difficult to translate the findings from animal studies into simple tests that can be used in humans to identify the specific mechanism(s) that produce each individual's CNP. One mechanism of CNP is the release of normal inhibitory control of thermosensory pathways or "thermosensory disinhibition", that is, the loss of the normal inhibition of pain by cold following damage to the temperature pathway. We will develop a thermal grill (TG) apparatus to enable the determination of a psychophysical measure called the thermal grill illusion (TGI) in individuals with CNP. The TG produces is an illusion of pain that can be used to detect the presence or absence cold inhibition of pain within the central nervous system. Prior research has shown that the TGI could be used for this purpose, but, as yet there is no commercially available TG. Furthermore, the TGI has only been tested on the hand or forearm of able-bodied individuals, but CNP can occur in any area of the body. The new TG ("REL-TG") will enable us to evaluate the TGI in multiple body regions among individuals with SCI-related CNP. This complex process requires close collaboration of engineers, clinicians, and neuroscientists to develop a simple test that can be used both clinically (at the bedside) and experimentally (in research studies) to identify the existence of a pain producing mechanism among individuals with CNP. The final phase of this project will provide pilot data for future studies that will identify subgroups of patients with TGI and allow correlation of the findings with the underlying CNP mechanism(s). Successful REL-TG development and testing will represent a major advancement in the ability to guide mechanism-based therapeutic approaches for CNP.